Gender differences in sleep apnea: a study of the catalan population Authors: Brenda Biaani León-Gómez, Maria del Mar Rodriguez Alvarez, Jesús Pujol Salud, Eulàlia Borrell Thio, Susana Erazo, Josep Roca Antonio, Pere Torán-Monserrat Published: 2026 ABSTRACT AbstractTo analyse sex differences in the distribution and comorbidity profile of adults with diagnosed obstructive sleep apnoea (OSA) and no prior cardiovascular disease, stratified by body mass index (BMI). We conducted a retrospective cross-sectional study of 3886 adults with diagnosed OSA. Data were obtained from the SIDIAP database and included individuals with OSA recorded between 1 January 2009 and 31 December 2016 and no previous cardiovascular disease. Analyses were stratified by sex. Variables included age, socioeconomic deprivation (MEDEA index), BMI, smoking, alcohol consumption, cardiometabolic comorbidities, and cardiovascular risk estimated with the REGICOR function. Chi-square tests were used to compare variables by sex and across BMI categories within each sex. Of the 3886 individuals included, 28.8% were women. Most participants were older than 40 years (92.6%). Men had higher proportions of alcohol consumption, smoking, hypertriglyceridaemia, hyperuricaemia, and less favourable REGICOR cardiovascular risk categories. Women showed higher proportions of hypertension, diabetes mellitus, and HbA1c ≥ 6.5%. Among those with available BMI data, women were more frequently represented in the highest BMI category, whereas men were more often represented in the lowest BMI category. Relevant sex-related differences were observed in the clinical profile, comorbidities, cardiometabolic risk factors, and health behaviours of adults with diagnosed OSA. These findings support the need for sex-sensitive approaches to the diagnosis and management of OSA, particularly to improve identification and care in women.Subject terms: Respiratory tract diseases, Diagnosis, Disease prevention, Health services, Public health Introduction Obstructive sleep apnoea (OSA) is the most common sleep-related breathing disorder and is characterized by recurrent episodes of upper airway obstruction during sleep1,2. OSA involves repetitive pharyngeal collapse that may be complete, resulting in apnoea, or partial, resulting in hypopnoea3,4. These events compromise gas exchange, causing oxygen desaturation, hypercapnia, and sleep fragmentation1. OSA is associated with hypertension, cardiovascular disease, cerebrovascular events5,6, and type 2 diabetes mellitus7. In addition, the excessive daytime sleepiness associated with OSA has been linked to a higher risk of accidents and a poorer quality of life8. There is substantial evidence that OSA differs between men and women9. Reported prevalence estimates are higher in men (22%) than in women (17%)10. However, the clinical expression of OSA in women is often less likely to include the classic symptom pattern of loud snoring, excessive daytime sleepiness, or choking awakenings. Instead, women more frequently report insomnia, fatigue, headaches, mood disturbances, and low energy, which may delay diagnosis and contribute to under-recognition11. Women also differ from men in polysomnographic characteristics, generally showing less severe parameters, a higher prevalence of REM-related events, a lower prevalence of positional OSA, and a predominance of hypopnoeas12. Additional mechanisms that may influence the development or progression of OSA in women, including menopause, are also being actively investigated13. Because OSA is associated with cardiovascular risk14, early detection, diagnosis, and treatment are important to reduce downstream complications. Delayed recognition may contribute to inequities in care, particularly if diagnostic suspicion differs by sex. Investigating these differences may help refine diagnostic and therapeutic strategies and improve understanding of the relationship between OSA, cardiometabolic risk, and clinical presentation in women. This study therefore examined sex differences in the clinical profile and comorbidities of adults with diagnosed OSA and no prior cardiovascular disease, stratified by BMI, to generate clinically relevant information for improving OSA diagnosis and management in Catalonia. Methodology Study design & data source We conducted a retrospective cross-sectional study of 3886 individuals with OSA and no prior cardiovascular disease, stratified by sex. Information was obtained from the SIDIAP (Information System for the Development of Research in Primary Care) database, a computerized database containing anonymized patient records for approximately 5.8 million patients from 279 Catalan Health Institute (ICS) primary care and hospital centres, representing around 80% of the Catalan population. The ICS uses the eCAP clinical software to record healthcare information. Health professionals register data using diagnostic codes and structured forms for variables such as smoking history and BMI. SIDIAP integrates primary care electronic health records with other linked databases, including data from the Hospital Discharge Minimum Data Set (minimum basic data set CMBD, for its acronym in Spanish), pharmacy dispensing records, and the National Mortality Registry. The study was approved by the IDIAP Jordi Gol Research Ethics Committee (registration number P13/069). Variables To define the SIDIAP OSA cohort, we included all adults aged 18 years or older who met the eligibility criteria for OSA and excluded those with a previous history of cardiovascular disease. The analysis comprised individuals with an index diagnosis of OSA recorded between 1 January 2009 and 31 December 2016. The index date was defined as the date of the recorded OSA diagnosis. Because this study was based on routine clinical records rather than a standardized baseline visit, variables were not necessarily recorded on the same date. Laboratory parameters were defined using the measurement closest to the index date available in the electronic health record, whereas comorbidities were identified from coded diagnoses recorded in the clinical history. We selected the study period because it corresponded to the temporal window for which a research-validated SIDIAP dataset was available. Restricting the analysis to this period also helped maximize internal consistency in the diagnostic framework used across participating centres, thereby reducing heterogeneity in OSA event classification over time. OSA cases were identified from linked SIDIAP primary care records and hospital discharge data from the CMBD. Because diagnostic coding varied according to data source and year of registration during the study period, case identification was based on the coding systems available in each source (ICD-9-CM and/or ICD-10-ES) and on an operational definition using the “OSA group” included in the research extraction. Records corresponding to individuals permanently living in long-term care institutions, such as nursing homes, intermediate care facilities, or other chronic care institutions, were excluded using predefined institutional residence codes. Individuals with previously diagnosed cardiovascular disease in either hospital or primary care records were also excluded. Additional exclusion criteria were operationalized using predefined diagnostic groups from the SIDIAP research extraction. These included the cerebrovascular disease group (“AVC_tots”), used to identify previous cerebrovascular disease, and the sleep disorders group other than OSA (“TRSON”), used to exclude individuals with other recorded sleep disorders. Individuals with a hospital diagnosis of OSA in which OSA was not the main diagnosis were also excluded, as were individuals with unconfirmed suspected OSA and terminal patients identified in primary care as complex chronic patients or patients with advanced chronic disease. Cardiovascular risk was estimated using the REGICOR score, which is based on age, sex, smoking status, diabetes mellitus, total cholesterol, HDL cholesterol, and systolic and diastolic blood pressure. REGICOR estimates the 10-year risk of myocardial infarction, angina pectoris, and other cardiovascular events. For this study, REGICOR risk was categorized as low ( < 5%), moderate (5.0–9.9%), high (10.0–14.9%), and very high ( ≥ 15.0%). Previous cardiovascular disease was operationally defined using ICD-10-coded diagnoses recorded before the index OSA diagnosis, including ischaemic heart disease (I20–I25), heart failure (I50), and cerebrovascular disease (I60–I69)15. The variables of interest included age, categorized as > 40 years and ≤ 40 years, and the MEDEA socioeconomic deprivation index16, categorized into five quintiles from Quintile 1 (least deprived) to Quintile 5 (most deprived).15 BMI was categorized into three predefined groups: < 35.0 kg/m², 35.0–39.9 kg/m², and ≥ 40.0 kg/m². The < 35.0 kg/m² category was clinically heterogeneous, as it included individuals with normal weight, overweight, and class I obesity. The upper two categories broadly corresponded to class II and class III obesity, respectively14. This pragmatic categorization was used to preserve sufficient sample size and analytical stability in sex-stratified analyses. Tobacco use was analysed as a dichotomous variable (smoker vs non-smoker). Hypertension, hypercholesterolaemia, hypertriglyceridaemia, diabetes mellitus, chronic hyperglycaemia (HbA1c ≥ 6.5%), and hyperuricaemia were evaluated as binary variables (yes/no). Finally, alcohol consumption risk was classified using the risk consumption recorded in the primary care medical history17. Three categories were used: Risk 0, non-drinker; Risk 1, low-risk consumption; and Risk 2, risky drinking. The thresholds differed by sex according to weekly standard drink units. Analysis All analyses were stratified by sex. Descriptive comparisons between women and men included age, MEDEA index, alcohol consumption, smoking, hypertension, hypercholesterolaemia, hypertriglyceridaemia, diabetes mellitus, HbA1c ≥ 6.5%, hyperuricaemia, and REGICOR cardiovascular risk. Alcohol consumption was collapsed into drinker (ALRIS 1–2) versus non-drinker (ALRIS 0) for the main analyses. Within each sex, these characteristics were also described across the three BMI categories. The chi-square test was used for comparisons, and a p-value of < 0.05 was considered statistically significant. Statistical analyses were performed using R version 4.3.218. Ethical declarations This study did not involve the direct collection of data from human participants, as data were obtained from secondary sources. The ethics committee approved the use of these secondary databases (SIDIAP). In compliance with the Declaration of Helsinki, all data were anonymized to protect the privacy and confidentiality of the participants. Furthermore, the ethics committee reviewed and approved the research, aiming to benefit the Catalan population by contributing to potential improvements in the diagnosis, treatment, and/or health policies related to obstructive sleep apnea. Results Table 1Distribution of OSA between Men and Women in Catalonia (2009-2016). This table shows, among the 3886 individuals included, 1121 (28.8%) were women and 2765 (71.2%) were men. Most participants were older than 40 years (women 94.11%; men 92.04%). Men more frequently reported alcohol consumption and smoking than women (28.82% vs 9.90% and 48.72% vs 25.33%, respectively; both p < 0.001). Women had higher proportions of hypertension, diabetes mellitus, and HbA1c ≥ 6.5%, whereas men had higher proportions of hypertriglyceridaemia and hyperuricaemia. Hypercholesterolaemia did not differ significantly by sex. REGICOR cardiovascular risk categories were less favourable in men, with lower proportions in the low-risk category and higher proportions in the moderate, high, and very high-risk categories (p < 0.001). Table 1Distribution of OSA between Men and Women in Catalonia (2009-2016).VariableWomenMenP-value testN%N%Total112128,85%276571,15%<0.001Age > 40105594,11%254592,04%0.030 < = 40 years665,89%2207,96% Missing00,00%00,00% Total1121100,00%2765100,00%Index Medeaa Quintile 1948,39%2488,97%<0.001 Quintile 213912,40%43315,66% Quintile 320818,55%48917,69% Quintile 423721,14%54519,71% Quintile 521819,45%38413,89% Missing22520,07%66624,09% Total1121100,00%2765100,00%Alcohol Consumption Classification (ALRIS)b Drinker (ALRIS 1-2)1119,90%79728,82%<0.001 Non-drinker (ALRIS 0)101090,10%196871,18% Missing00,00%00,00% Total1121100,00%2765100,00%Tobacco consumption Yes28425,33%134748,72%<0.001 NO83774,67%141851,28% Missing00,00%00,00% Total1121100,00%2765100,00%Hypertension Yes67460,12%147253,24%<0.001 NO44739,88%129346,76% Missing00,00%00,00% Total1121100,00%2765100,00%Hypercholesterolemia Yes50344,87%116442,10%0.122 NO61855,13%160157,90% Missing00,00%00,00% Total1121100,00%2765100,00%Hypertriglyceridemia Yes201,78%1344,85%<0.001 NO110198,22%263195,15% Missing00,00%00,00% Total1121100,00%2765100,00%Diabetes Mellitus Yes28925,78%62022,42%0.028 NO83274,22%214577,58% Missing00,00%00,00% Total1121100,00%2765100,00%HbA1c > = 6.5% Yes18816,77%33111,97%0.001 NO18316,32%48717,61% Missing75066,90%194770,42% Total1121100,00%2765100,00%Hyperuricemia Yes1019,01%47917,32%<0.001 NO51145,58%92833,56% Missing50945,41%135849,11% Total1121100,00%2765100,00%REGICOR Low Risk: < 5%27124,17%41314,94%<0.001 Moderate Risk: 5-9,9%928,21%35512,84% High Risk: 10-14,9%90,80%833,00% Very high Risk: 15% or more30,27%361,30% Missing74666,55%187867,92% Total1121100,00%2765100,00%Percentages were calculated within each sex-specific column. Missing data are presented as a separate category.aMEDEA= Deprivation Index.bALRIS= Alcohol Consumption Classification. Distribution of OSA between Men and Women in Catalonia (2009-2016). Percentages were calculated within each sex-specific column. Missing data are presented as a separate category. aMEDEA= Deprivation Index. bALRIS= Alcohol Consumption Classification. Table 2Characteristics of women with OSA in Catalonia (2009–2016) according to BMI category. Among women with available BMI data, 47.49% had a BMI < 35.0 kg/m², 20.94% had a BMI of 35.0–39.9 kg/m², and 31.56% had a BMI ≥ 40.0 kg/m². Most women in all BMI categories were older than 40 years, although the proportion decreased as BMI increased (p = 0.007). No significant differences were observed across BMI categories for the MEDEA index, alcohol consumption, tobacco use, hypertension, hypercholesterolaemia, HbA1c ≥ 6.5%, or REGICOR risk categories. By contrast, hypertriglyceridaemia, diabetes mellitus, and hyperuricaemia varied significantly across BMI categories. Diabetes mellitus was more common in the higher BMI categories, whereas hyperuricaemia was highest in the BMI ≥ 40.0 kg/m² group. Table 2Characteristics of women with OSA in Catalonia (2009–2016) according to BMI category.VariableBMI ( < 35 IMC)BMI (35–39.9 IMC)BMI ( > = 40 IMC)p-valueN%N%N%Total16147,49%7120,94%10731,56%<0.001Age > 4015998,76%6895,77%9790,65%0.007 < = 40 years21,24%34,23%109,35% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Index Medeaa Quintile 11911,80%22,82%76,54%0.473 Quintile 21710,56%912,68%1614,95% Quintile 33018,63%1622,54%2321,50% Quintile 42414,91%1419,72%2119,63% Quintile 52817,39%1419,72%2119,63% Missing4326,71%1622,54%1917,76% Total161100,00%71100,00%107100,00%Alcohol Consumption Classificationc Drinker (1-2)2716,77%68,45%98,41%0.066 Non-drinker (0)13483,23%6591,55%9891,59% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Tobacco consumption Yes5232,30%1419,72%2422,43%0.069 NO10967,70%5780,28%8377,57% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Hypertension Yes10263,35%5070,42%7570,09%0.405 NO5936,65%2129,58%3229,91% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Hypercholesterolemia Yes8754,04%3143,66%4743,93%0.171 NO7445,96%4056,34%6056,07% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Hypertriglyceridemia Yes10,62%45,63%00,00%0.004 NO16099,38%6794,37%107100,00% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%Diabetes Mellitus Yes2817,39%2535,21%3633,64%0.002 NO13382,61%4664,79%7166,36% Missing00,00%00,00%00,00% Total161100,00%71100,00%107100,00%HbA1c > = 6.5% Yes2113,04%1622,54%2220,56%0.749 NO2314,29%1521,13%2927,10% Missing11772,67%4056,33%5652,34% Total161100,00%71100,00%107100,00%Hyperuricemia Yes84,97%912,68%1614,95%0.015 NO8854,66%4056,34%4844,86% Missing6540,37%2230,99%4340,19% Total161100,00%71100,00%107100,00%REGICOR Low Risk: < 5%5634,78%2129,58%2523,36%0,43 Moderate Risk: 5-9,9%148,70%79,86%1211,21% High Risk: 10-14,9%10,62%00,00%10,93% Very high Risk: 15% or more00,00%11,41%21,87% Missing9055,90%4259,15%6762,62% Total161100,00%71100,00%107100,00%Percentages were calculated within each BMI-category column. Missing data are presented as a separate category. First-row BMI percentages were calculated among women with available BMI data.aMEDEA= Deprivation Index.bBMI=Body Mass Index.cAlcohol Consumption Classification. Characteristics of women with OSA in Catalonia (2009–2016) according to BMI category. Percentages were calculated within each BMI-category column. Missing data are presented as a separate category. First-row BMI percentages were calculated among women with available BMI data. aMEDEA= Deprivation Index. bBMI=Body Mass Index. cAlcohol Consumption Classification. Table 3Characteristics of men with OSA in Catalonia (2009–2016) according to BMI category. Among men with available BMI data, 65.73% had a BMI < 35.0 kg/m², 22.98% had a BMI of 35.0–39.9 kg/m², and 11.30% had a BMI ≥ 40.0 kg/m². Most men in all BMI categories were older than 40 years, although the proportion was notably lower in the BMI ≥ 40.0 kg/m² group (p < 0.001). The MEDEA index differed significantly across BMI categories (p = 0.012), with greater representation of men in the more deprived quintiles in the higher BMI groups. Alcohol consumption also differed significantly across BMI categories and was most frequent in the BMI < 35.0 kg/m² group. No significant differences were observed for tobacco use, hypertension, hypercholesterolaemia, hypertriglyceridaemia, diabetes mellitus, HbA1c ≥ 6.5%, or REGICOR risk categories. Hyperuricaemia differed significantly across BMI categories and was most frequent in the BMI ≥ 40.0 kg/m² group. Table 3Characteristics of men with OSA in Catalonia (2009–2016) according to BMI category.VariableBMI ( < 35 IMC)BMI (35–39.9 IMC)BMI ( > = 40 IMC)p-valueN%N%N%Total51265,73%17922,98%8811,30%<0.001Age > 4048394,34%16994,41%6776,14%<0.001 < = 40 years295,66%105,59%2123,86% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Index Medeaa Quintile 15510,74%73,91%66,82%0.012 Quintile 28616,80%3016,76%66,82% Quintile 38115,82%3217,88%1618,18% Quintile 49819,14%3620,11%1921,59% Quintile 56312,30%3318,44%1921,59% Missing12925,20%4122,91%2225,00% Total512100,00%179100,00%88100,00%Alcohol Consumption Classificationc Drinker (1–2)22944,73%7139,66%2730,68%0.037 Non-Drinker (0)28355,27%10860,34%6169,32% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Tobacco consumption Yes25950,59%8648,04%5259,09%0.227 NO25349,41%9351,96%3640,91% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Hypertension Yes28355,27%11765,36%5461,36%0.051 NO22944,73%6234,64%3438,64% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Hypercholesterolemia Yes23245,31%8145,25%2831,82%0.056 NO28054,69%9854,75%6068,18% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Hypertriglyceridemia Yes214,10%73,91%44,55%0.970 NO49195,90%17296,09%8495,45% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%Diabetes Mellitus Yes12324,02%5932,96%2528,41%0.061 NO38975,98%12067,04%6371,59% Missing00,00%00,00%00,00% Total512100,00%179100,00%88100,00%HbA1c > = 6.5% Yes7013,67%3720,67%1213,64%0.226 NO10320,12%4022,35%2629,55% Missing33966,21%10256,98%5056,82% Total512100,00%179100,00%88100,00%Hyperuricemia Yes10520,51%3418,99%3034,09%0.001 NO21341,60%8145,25%2123,86% Missing19437,89%6435,75%3742,05% Total512100,00%179100,00%88100,00%REGICORLow Risk: < 5%12023,44%3519,55%1820,45%0,38Moderate Risk: 5-9,9%8817,19%3720,67%1618,18%High Risk: 10-14,9%203,91%42,23%11,14%Very high Risk: 15% or more71,37%42,23%33,41% Missing27754,10%9955,31%5056,82% Total512100,00%179100,00%88100,00%Percentages were calculated within each BMI-category column. Missing data are presented as a separate category. First-row BMI percentages were calculated among men with available BMI data.aMEDEA= Deprivation Index.bBMI=Body Mass Index.cAlcohol Consumption Classification. Characteristics of men with OSA in Catalonia (2009–2016) according to BMI category. Percentages were calculated within each BMI-category column. Missing data are presented as a separate category. First-row BMI percentages were calculated among men with available BMI data. aMEDEA= Deprivation Index. bBMI=Body Mass Index. cAlcohol Consumption Classification. Discussion This study identified sex-related differences in BMI distribution, health behaviours, cardiometabolic profile, and cardiovascular risk among adults with diagnosed OSA and no prior cardiovascular disease in a real-world clinical cohort from Catalonia. These findings have clinical and epidemiological relevance for the diagnosis and management of OSA. A key strength of the study is the use of routine data from a large regional healthcare system, which allowed characterization of a clinically diagnosed OSA cohort within routine practice. Although the findings are most directly applicable to similar healthcare settings, they may also be informative internationally by illustrating how healthcare organization and diagnostic pathways can shape the characteristics of recorded OSA cohorts. The observed differences between women and men with OSA may reflect a combination of anatomical, hormonal, clinical, and social determinants19–21. Sex-related anatomical differences in the upper airway may influence airway collapsibility and OSA progression, while hormonal factors may partly modulate prevalence and severity19–21. Women also tend to present at older ages and with higher BMI, and their symptom profile may be less likely to match the classic presentation historically associated with OSA22,23. In our cohort, most individuals younger than 40 years were men, which is consistent with the possibility that men are diagnosed earlier because their presentation more often aligns with conventional clinical suspicion, whereas women may remain underdiagnosed for longer24. Epidemiological studies also suggest sex-specific associations between OSA and factors such as physical inactivity, hypertension, and daytime sleepiness in women25. Recent literature further indicates that the traditional distinction between “typical” and “atypical” OSA symptoms may be overly simplistic. Symptom-based cluster analyses have identified reproducible clinical phenotypes, including excessively sleepy, disturbed-sleep or insomnia-related, and minimally symptomatic groups, with some cohorts also identifying intermediate or moderately sleepy profiles. These phenotypes differ not only in symptom burden but also in comorbidity patterns, cardiovascular risk, and potentially treatment response, underlining that OSA is not a clinically homogeneous disorder. Female-specific cluster analyses have similarly shown that women with OSA do not conform to a single presentation, but may instead show classic symptomatic, paucisymptomatic, or mood and non-restorative sleep profiles. Although our dataset did not include standardized symptom scales or sufficient clinical detail to perform phenotypic clustering, this framework helps contextualize the sex-related variability observed in our study and supports a more individualized diagnostic and therapeutic approach to OSA26. Among participants with available BMI data, women were more frequently represented in the highest BMI category, whereas men were more often represented in the lowest BMI category. Obesity is a well-established risk factor for OSA, and this pattern may reflect differences in fat distribution, hormonal factors, health behaviours, help-seeking patterns, or diagnostic pathways. Men in our cohort also had markedly higher alcohol consumption and smoking prevalence, which is consistent with broader behavioural patterns described in the general population. Because both alcohol and tobacco may worsen OSA and contribute to adverse health outcomes, these sex-related differences are clinically important. The cardiometabolic profile also differed by sex. Men had higher proportions of hypertriglyceridaemia, hyperuricaemia, and less favourable REGICOR cardiovascular risk categories, whereas women had higher proportions of hypertension, diabetes mellitus, and HbA1c ≥ 6.5%. Hypercholesterolaemia was similar in both sexes. Taken together, these findings suggest that sex differences in OSA are not captured by a simple “better” or “worse” overall risk profile, but rather by distinct patterns of cardiometabolic burden27. Within the BMI-stratified analyses, diabetes mellitus and hyperuricaemia varied across BMI categories in women, while hyperuricaemia and socioeconomic deprivation varied across BMI categories in men28,29. By contrast, REGICOR risk categories did not differ significantly across BMI strata within either sex29, or these subgroup patterns should therefore be interpreted cautiously28,30. Our findings should also be interpreted considering the broader literature linking OSA with hypertension, diabetes, and cardiovascular risk31,32. Rather than indicating uniform sex-based disadvantage, our results reinforce the need to consider sex-related heterogeneity in clinical presentation, cardiometabolic comorbidity, and diagnostic pathways. This is especially relevant in women, in whom OSA may be recognized later or through a different constellation of symptoms and risk factors23,33,34. Diabetes mellitus was less prevalent than hypertension in the study overall; however, the sex-specific pattern should be interpreted in light of the higher prevalence of diagnosed diabetes and HbA1c ≥ 6.5% observed in women in this cohort. This aligns with other studies that find a high prevalence of OSA in patients with DM2 and a significant association between the severity of OSA and glycemic control, especially in men with DM235,36. However, in our study, we observed higher levels of HbA1c in women, reflecting suboptimal glycemic control. This is consistent with other studies showing that women with OSA have significantly higher HbA1c levels, suggesting poorer glycemic control37,38. Limitations This study has several limitations. First, some variables had a high proportion of missing data, including the MEDEA index, HbA1c, hyperuricaemia, REGICOR, and BMI, which may have affected the precision and representativeness of some analyses. In particular, BMI-stratified analyses were based only on individuals with available BMI data. Second, BMI has well-known limitations as a proxy for adiposity because it does not distinguish between fat mass and lean mass39. In addition, the BMI < 35.0 kg/m² category grouped clinically heterogeneous individuals, including those with normal weight, overweight, and class I obesity, which may have limited the detection of more nuanced differences across BMI strata, particularly in sex-stratified analyses. Third, although multivariable approaches could provide a more refined assessment of factors associated with increasing BMI levels in individuals with OSA, the available sample size and data structure did not support such analyses with sufficient robustness. Fourth, relevant clinical variables were unavailable in the extract, including key sleep-study severity measures such as the apnoea-hypopnoea index, oxygen desaturation index, and standardized assessments of daytime sleepiness. In addition, some aspects of the diagnostic process could not be characterized precisely. Specifically, the available data did not include standardized information on the diagnostic modality used to confirm OSA, such as polysomnography versus respiratory polygraphy, nor a reliable indicator of the exact healthcare setting in which the diagnosis was established. Because SIDIAP integrates primary care electronic health records with linked sources such as hospital discharge data, the cohort may include diagnoses recorded across different levels of care, potentially introducing heterogeneity related to referral pathways and diagnostic practices. However, this heterogeneity could not be formally assessed. Finally, because this study was based on routine clinical records rather than a standardized baseline assessment, not all variables were recorded at the same clinical time point. Laboratory parameters were obtained from the measurement closest to the index OSA diagnosis, whereas comorbidities were identified from coded diagnoses that may have been recorded before or after that date. Temporal variability across variables therefore cannot be excluded, and some measures may not reflect the patient’s exact status at the time of OSA diagnosis. These constraints limit comparability across variables, reduce temporal precision, and preclude causal interpretation. In addition, the study period, 2009–2016, limits the contemporary applicability of the findings, as OSA diagnostic criteria, scoring practices, and care pathways have evolved over time. Future studies using more recent data, richer clinical characterization, and more robust multivariable approaches may help clarify how sex, BMI, clinical presentation, and cardiometabolic factors are interrelated within diagnosed OSA populations. Conclusions Relevant sex-related differences were observed in the clinical profile, comorbidities, cardiometabolic risk factors, and health behaviours of adults with diagnosed OSA. These findings support the need for sex-sensitive approaches to diagnosis and management, particularly to improve the identification and care of women with OSA. Acknowledgements This research received no specific funding from public, commercial, or non-profit funding agencies. Author contributions B B L G, and P T M conceptualized the study. B B L G and P T M developed the methodology. B B L G drafted the main manuscript text. M M R A, P T M, J P S, E B T, and S E conducted a critical review of the manuscript, providing key and relevant insights. J R A performed all statistical analyses, prepared the tables, and contributed to the interpretation of the results. All authors reviewed and approved the final manuscript. Data Availability No new datasets were generated during the current study. The data analysed were obtained from an extraction of the SIDIAP database and are subject to data protection and institutional access restrictions. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Brenda Biaani León-Gómez, Pere Torán-Monserrat. Contributor Information Brenda Biaani León-Gómez, Email: bleongo.mn.ics@gencat.cat. Pere Torán-Monserrat, Email: ptoran.bnm.ics@gencat.cat. References Associated Data Data Availability Statement No new datasets were generated during the current study. The data analysed were obtained from an extraction of the SIDIAP database and are subject to data protection and institutional access restrictions.